Genetic basis of the complex pathological manifestations of collagen disease: Lessons from MRL/lpr and related mouse models

International Reviews of Immunology

Volumn 19, Issue 4-5, 2000, Pages 473-498

  Nose, M ^a   Nishihara, M ^a   Fujii, H ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Allelic polymorphism; Autoimmune disease; Fas; Genetic dissection; Polygene

Indexed keywords

EID: 0033835906     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830180009055508     Document Type: Article

References (90)

1. Diffuse collagen disease. Acute disseminated lupus erythematosus and diffuse scleroderma
2. The 'overlap syndrome' (Rheumatoid arthritis with features of systemic lupus): An 8-year follow-up with 2 postmortems
3. Abnormalities induced by the mutant gene lpr: Expansion of unique lymphocyte subset
4. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains
5. Mechanisms of autoantibody production in autoimmune MRL mice
6. Circulating anti-DNA-rheumatoid factor complexes in MRL/1 mice
7. Self-associating IgG rheumatoid factors in MRL/1 autoimmune mice
8. Induction of various autoantibodies by mutant gene lpr in several strains of mice
9. Murine models of systemic lupus erythematosus
10. Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL/Mp-lpr/lpr mice: A spontaneous model for human microscopic angitis
11. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus
12. Age-associated increase in interleukin 6 in MRL/lpr mice
13. Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice
14. A spontaneous rheumatoid arthritis-like disease in MRL/1 mice
15. Etiopathogenesis of the rheumatoid arthritis-like disease in MRL/1 mice. The histomorphologic basis of joint destruction
16. Immunohistochemical characterization of synovial cells in arthritic MRL-lpr/lpr mice
17. Pathogenic significance of serum components in the development of autoimmune polyarthritis in MRL/Mp mice bearing the lymphoproliferation gene
18. Sialadenitis in the MRL/1 mouse: Morphological and immunohistochemical characterization of resident and infiltrating cells
19. Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice: A histologic and immunocytochemical analysis
20. Role of macrophages in the development of arteritis in MRL strains of mice with a deficit in Fas-mediated apoptosis
21. Sjogren's syndrome in MRL/1 and MRL/n mice
22. Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism
23. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apotosis
24. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
25. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice
26. Fas and Fas ligand: A death factor and its receptor
27. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
28. + T cells
29. + lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway
30. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice
31. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice
32. Lpr and gld single gene models of systemic autoimmunity and lymphoproliferative disease
33. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis
34. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules
35. Genetic basis of vasculitis in lupus mice
36. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
37. Expression of the Fas ligand in cells of T cell lineage
38. Rheumatoid diseases in an MRL strain of mice with a deficit in the functional Fas ligand
39. + T cells
40. Expression and function of the murine CD95/FasR/APO-1 receptor in relation to B cell ontogeny
41. Expression and function of Fas antigen on activated murine B cells
42. Immune complex-degradation ability of macrophages in MRL/Mp-lpr/lpr lupus mice and its regulation by cytokines
43. Amelioration of systemic autoimmune disease by the stimulation of apoptosis-promoting receptor Fas with anti-Fas mAb
44. Systemic lupus erythematosus
45. Vascular lesions in mice with a deficit in Fas-mediated apoptosis and their transfer
46. Arteritis in a novel congenic strain of mice derived from MRL/lpr lupus mice: Genetic dissociation from glomerulonephritis and limitted autoantibody production
47. Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities
48. SCG/Kj mice develop crescentic glomerulonephritis, vasculitis and MPO-specific P-ANCA
49. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
50. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
51. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity
52. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: A molecular and immunological analysis
53. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease
54. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
55. Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations
56. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis
57. Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/lpr lupus mouse
58. Induction of different types of glomerulonephritis by monoclonal antibodies derived from MRL/lpr lupus mouse
59. Sequence analysis of the germline VH gene corresponding to a nephritogenic antibody in MRL/lpr mice
60. A novel germline VH gene encoding a murine nephritogenic autoantibody
61. Vasculitis-susceptible genes in mice with a deficit in Fas-mediated apoptosis
62. Genetic dissection of the complex pathological manifestations of collagen disease in MRL/lpr mice
63. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
64. Protein tyrosine kinase p56 (lck) controls allelic exclusion of T-cell receptor β chain genes
65. Hereditary deficiencies in man: Summary of reported deficiencies
66. Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: Additive and hierarchical properties on polygenic inheritance
67. Positional cloning of the APECED gene
68. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains
69. Genetic analysis of autoimmune disease
70. Genetic analysis of MRL-lpr mice: Relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci
71. Host modifier genes affect mouse autoimmunity induced by the lpr gene
72. Loci predisposing to autoimmunity in MRL-Fas(lpr) and C57BL/6-Fas(lpr) mice
73. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus
74. Genetic analysis of a mammalian wound-healing trait
75. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus
76. Vasculitis in systemic lupus erythematosus
77. Lupus erythematosus in the 1980s: A survey of 570 patients
78. Lupus nephritis: Lessons from the path lab
79. The muskuloskeletal system
80. Articular manifestations of systemic lupus erythematosus
81. Muscle involvement in systemic lupus erythematosus
82. Lupus lung
83. Cardiovascular manifestations of systemic lupus erythematosus
84. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases
85. Cutaneous manifestations of lupus erythematosus
86. Gastrointestinal and hepatic manifestations
87. Pancreatitis: A rare manifestation of systemic lupus erythematosus
88. Disease activity in systemic lupus erythematosus: Report of the Concensus Study Group of the European Workshop for Rheumatology Research I. A descriptive analysis of 704 European lupus patients
89. The liver in systemic lupus erythematosus: Pathologic analysis of 52 cases and review of Japanese autopsy registry data